Combined differentiating therapy for myelodysplastic syndromes: a phase II study.
Ferrero D, Bruno B, Pregno P, Stefani S, Larizza E, Ciravegna G, Luraschi A, Vietti-Ramus G, Schinco P, Bazzan M, Gallo E, Pileri A.
Ferrero D, et al. Among authors: pregno p.
Leuk Res. 1996 Oct;20(10):867-76. doi: 10.1016/0145-2126(95)00156-5.
Leuk Res. 1996.
PMID: 8960111
Clinical Trial.